Joint EMA/EORTC Workshop
February 29
Amsterdam, NL (Hybrid Event)
The European Medicines Agency (EMA) and the European Organisation for Research and Treatment of Cancer (EORTC) are jointly organising a workshop called “How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?”
This workshop will bring together international experts from academia, learned societies, patients, regulatory agencies, health technology assessment bodies, and industry.
Date: Thursday, 29 February 2024
Location: European Medicines Agency, Amsterdam
Next events
EORTC Melanoma Group Autumn Meeting 2024
September 11 - September 12
Barcelona, Spain
CDDF-EORTC Workshop on Innovation and Access in Rare Cancers
September 23 - September 24
Amsterdam, NL (Hybrid Event)
EORTC Quality of Life Group Autumn Meeting 2024
September 26 - September 27
Innsbruck, Austria
EORTC Pathobiology Group Autumn Meeting 2024
October 2
Virtual Event
EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 2024
October 9 - October 11
Lausanne, Switzerland
